Literature DB >> 22893405

The GK rat: a prototype for the study of non-overweight type 2 diabetes.

Bernard Portha1, Marie-Hélène Giroix, Cecile Tourrel-Cuzin, Hervé Le-Stunff, Jamileh Movassat.   

Abstract

Type 2 diabetes mellitus (T2D) arises when the endocrine pancreas fails to secrete sufficient insulin to cope with the metabolic demand because of β-cell secretory dysfunction and/or decreased β-cell mass. Defining the nature of the pancreatic islet defects present in T2D has been difficult, in part because human islets are inaccessible for direct study. This review is aimed to illustrate to what extent the Goto Kakizaki rat, one of the best characterized animal models of spontaneous T2D, has proved to be a valuable tool offering sufficient commonalities to study this aspect. A comprehensive compendium of the multiple functional GK abnormalities so far identified is proposed in this perspective, together with their time-course and interactions. A special focus is given toward the pathogenesis of defective β-cell number and function in the GK model. It is proposed that the development of T2D in the GK model results from the complex interaction of multiple events: (1) several susceptibility loci containing genes responsible for some diabetic traits; (2) gestational metabolic impairment inducing an epigenetic programming of the offspring pancreas and the major insulin target tissues; and (3) environmentally induced loss of β-cell differentiation due to chronic exposure to hyperglycemia/hyperlipidemia, inflammation, and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893405     DOI: 10.1007/978-1-62703-068-7_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  35 in total

1.  Rat Models of Metabolic Syndrome.

Authors:  Anne E Kwitek
Journal:  Methods Mol Biol       Date:  2019

2.  Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue.

Authors:  Jefferson C Frisbee; Matthew T Lewis; Jonathan D Kasper; Paul D Chantler; Robert W Wiseman
Journal:  J Appl Physiol (1985)       Date:  2018-12-20

3.  Neurolytic celiac plexus block enhances skeletal muscle insulin signaling and attenuates insulin resistance in GK rats.

Authors:  Jun Li; Tao Chen; Kun Li; Hongtao Yan; Xiaowei Li; Yun Yang; Yulan Zhang; Bingyin Su; Fuxiang Li
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

4.  The Effects of One-Anastomosis Gastric Bypass on Glucose Metabolism in Goto-Kakizaki Rats.

Authors:  Lorea Zubiaga; Rafael Abad; Jaime Ruiz-Tovar; Pablo Enriquez; Juan Antonio Vílchez; Mireia Calzada; José Antonio Pérez De Gracia; Mervyn Deitel
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

5.  The insulin resistance is reversed by exogenous 3,5,3'triiodothyronine in type 2 diabetic Goto-Kakizaki rats by an inflammatory-independent pathway.

Authors:  Ana Carolina Panveloski-Costa; Wilson Mitsuo Tatagiba Kuwabara; Ana Cláudia Munhoz; Camila Ferraz Lucena; Rui Curi; Angelo Rafael Carpinelli; Maria Tereza Nunes
Journal:  Endocrine       Date:  2020-01-29       Impact factor: 3.633

6.  HSF1 acetylation decreases its transcriptional activity and enhances glucolipotoxicity-induced apoptosis in rat and human beta cells.

Authors:  Indri Purwana; Jun J Liu; Bernard Portha; Jean Buteau
Journal:  Diabetologia       Date:  2017-05-25       Impact factor: 10.122

Review 7.  Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models.

Authors:  Anne-Claire Dorsemans; David Couret; Anaïs Hoarau; Olivier Meilhac; Christian Lefebvre d'Hellencourt; Nicolas Diotel
Journal:  Neurogenesis (Austin)       Date:  2017-01-31

Review 8.  Review of Pharmacokinetic Data of Different Drug Classes in Goto-Kakizaki Rats, a Non-obese Model for Type 2 Diabetes Mellitus: Case Studies and Perspectives.

Authors:  Harilal Patel; Poonam Giri; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

Review 9.  Alternatives to the Streptozotocin-Diabetic Rodent.

Authors:  M A Yorek
Journal:  Int Rev Neurobiol       Date:  2016-03-28       Impact factor: 3.230

10.  Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells.

Authors:  Xiaohong Wang; Wei Huang; Guansheng Liu; Wenfeng Cai; Ronald W Millard; Yigang Wang; Jiang Chang; Tianqing Peng; Guo-Chang Fan
Journal:  J Mol Cell Cardiol       Date:  2014-05-10       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.